Manuscript
Serial Assessment of NT-proBNP and High-Sensitivity Cardiac Troponin with Glucagon-Like Peptide-1 Receptor Agonist Therapy in Type 2 Diabetes: Insights from EXSCEL
Veraprapas Kittipibul et al.
Am Heart J. 2026;299:107475
Manuscript
Semaglutide treatment fails but might prevent Alzheimer's disease
Ivan Koychev et al.
Lancet 2026;408:602-603
Manuscript
To cluster or not to cluster? A comparison of approaches to targeting type 2 diabetes glucose lowering therapy in the TRIMASTER Crossover Trial
Güdemann LM et al.
Diabetes Care 2026;49:1458-1466
Manuscript
A Validated, Modifiable Proteomic Score from the EXSCEL Trial Predicts Cardiovascular Events in Diabetes.
Corey KM et al.
JCI Insight. 2026
Manuscript
Leveraging External Controls in Clinical Trials: Estimands, Estimation, Assumptions
Bo Liu et al.
J Biopharm Stat. 2026
Manuscript
Precision prescribing of SGLT2-inhibitors in people with type 2 diabetes for primary prevention of heart failure: model development and validation study
Katherine G Young et al.
Diabetes Care 2026;49:1115-1123